Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- manufacturers
- THR-β agonist 3
-
- $3420.00
-
2026-05-21
- CAS:2656400-84-7
- Purity:
- Supply Ability: 10g
|
| | Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Basic information |
| Product Name: | Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- | | Synonyms: | Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)-;THR-β agonist 3 | | CAS: | 2656400-84-7 | | MF: | C29H32ClO5P | | MW: | 526.99 | | EINECS: | | | Product Categories: | | | Mol File: | 2656400-84-7.mol | ![Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Structure](CAS/20211123/GIF/2656400-84-7.gif) |
| | Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Chemical Properties |
| Boiling point | 668.3±55.0 °C(Predicted) | | density | 1.31±0.1 g/cm3(Predicted) |
| | Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Usage And Synthesis |
| Uses | THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1]. | | References | [1] Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1. |
| | Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Preparation Products And Raw materials |
|